These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37471076)

  • 1. Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSim.
    Kalyta A; Ruan Y; Telford JJ; De Vera MA; Peacock S; Brown C; Donnellan F; Gill S; Brenner DR; Loree JM
    JAMA Oncol; 2023 Oct; 9(10):1432-1436. PubMed ID: 37471076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 4. The projected health and economic impact of increased colorectal cancer screening participation among Canadians by income quintile.
    Adegbulugbe AA; Farah E; Ruan Y; Yong JHE; Cheung WY; Brenner DR
    Can J Public Health; 2024 Jun; 115(3):384-394. PubMed ID: 38502494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
    Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Trends in Colorectal Cancer Incidence Among Older and Younger Adults in Canada.
    Brenner DR; Heer E; Sutherland RL; Ruan Y; Tinmouth J; Heitman SJ; Hilsden RJ
    JAMA Netw Open; 2019 Jul; 2(7):e198090. PubMed ID: 31365108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering the colorectal cancer screening age improves predicted outcomes in a microsimulation model.
    Fisher DA; Saoud L; Finney Rutten LJ; Ozbay AB; Brooks D; Limburg PJ
    Curr Med Res Opin; 2021 Jun; 37(6):1005-1010. PubMed ID: 33769894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
    Fisher DA; Karlitz JJ; Jeyakumar S; Smith N; Limburg P; Lieberman D; Fendrick AM
    J Med Econ; 2021; 24(1):654-664. PubMed ID: 33902366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time Trends in Colorectal Cancer Incidence Rates by Income and Age at Diagnosis in Canada From 1992 to 2016.
    Decker KM; Lambert P; Bravo J; Demers A; Singh H
    JAMA Netw Open; 2021 Jul; 4(7):e2117556. PubMed ID: 34279645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia.
    Naber SK; Almadi MA; Guyatt G; Xie F; Lansdorp-Vogelaar I
    Saudi J Gastroenterol; 2021; 27(4):208-216. PubMed ID: 33835054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness and cost-effectiveness analysis of a urine metabolomics test vs. alternative colorectal cancer screening strategies.
    Barichello S; Deng L; Ismond KP; Loomes DE; Kirwin EM; Wang H; Chang D; Svenson LW; Thanh NX
    Int J Colorectal Dis; 2019 Nov; 34(11):1953-1962. PubMed ID: 31673772
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.